Free Trial

SOPHiA GENETICS Q4 2023 Earnings Report

SOPHiA GENETICS logo
$3.43 +0.54 (+18.69%)
As of 01/13/2025 04:00 PM Eastern

SOPHiA GENETICS EPS Results

Actual EPS
-$0.37
Consensus EPS
-$0.25
Beat/Miss
Missed by -$0.12
One Year Ago EPS
-$0.22

SOPHiA GENETICS Revenue Results

Actual Revenue
$17.05 million
Expected Revenue
$16.78 million
Beat/Miss
Beat by +$270.00 thousand
YoY Revenue Growth
N/A

SOPHiA GENETICS Announcement Details

Quarter
Q4 2023
Time
Before Market Opens

Conference Call Resources

Conference Call Audio

SOPHiA GENETICS Earnings Headlines

Morgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)
Greatest crypto bull market in history?
A crypto storm is coming Right now, conditions are in place for a historic move we expect will be the greatest crypto bull market since Bitcoin emerged. According to one crypto expert (who began mining Bitcoin in his garage in 2013): “We are in the early stages of a crypto mania – the calm before the storm.” But most Americans could be blindsided by what's about to happen.
Craig-Hallum bullish on Sophia Genetics, initiates with a Buy
SOPHiA GENETICS (SOPH) Receives a Buy from RBC Capital
See More SOPHiA GENETICS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SOPHiA GENETICS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SOPHiA GENETICS and other key companies, straight to your email.

About SOPHiA GENETICS

SOPHiA GENETICS (NASDAQ:SOPH) operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

View SOPHiA GENETICS Profile

More Earnings Resources from MarketBeat